- 
				Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease
- 
				Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
- 
				Quality of life and living with Parkinson’s in Ireland
- 
				Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong
- 
				Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment
- 
				Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology
- 
				Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease
- 
				Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease
- 
				Quantifying daily living transitions in patients with Parkinson’s disease using a body-fixed sensor
- 
				Quantifying turning behavior in Parkinson’s disease patients using mobile technology
- 
				Quantitative analysis of tremor in patients with cerebellar and brainstem lesions
- 
				Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)
- 
				Quantitative assessment of DBS-induced gait disorder in patients with essential tremor
- 
				Quantitative measurements of deficit type and severity in focal embouchure dystonia
- 
				Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy
2016 International Congress
June 19-23, 2016. Berlin, Germany.
